BiotechTube
Home/Toralgen/Andy Glasebrook
AG

Andy Glasebrook

VP of Autoimmune Research

Toralgen

Therapeutic Areas

Metabolic DiseasesAutoimmune DisordersRare Genetic Disorders

Toralgen Pipeline

DrugIndicationPhase
Nanopill PlatformDiabetes (e.g., oral peptide/bio logic delivery)Pre-clinical

Leadership Team at Toralgen

GR
Gerald Rea
CEO
DM
Dave Moore
COO
EB
Ed Bastyr
CMO
TF
Tarek Fahmy
Co-Founder, Inventor
DM
Dod Micheal
VP of Metabolic Diseases
View full Toralgen profile